Naoki Takamatsu, Misuzu Nakashima, Kei Matsuura, Ikue Umemoto, Masaya Ito, Junichiro Kanazawa, Hirofumi Tomiyama, Masaki Kondo, Hisateru Tachimori, Tomohiro Nakao, et al. A multicenter, single-group, open feasibility study of a new individual cognitive behavioral therapy program for adult Japanese patients with attention-deficit/hyperactivity disorder: Study protocol (In Print). Psychiatry and Clinical Neurosciences Reports. 2024
So Sugita, Kotone Hata, Krandhasi Kodaiarasu, Naoki Takamatsu, Kentaro Kimura, Christian Miller, Lecsy Gonzalez, Ikue Umemoto, Keitaro Murayama, Tomohiro Nakao, et al. Psychological treatments for mental health symptoms associated with COVID-19 infection: A scoping review. Psychiatry and Clinical Neurosciences Reports. 2024. 3. 3
So Sugita, Kotone Hata, Naoki Takamatsu, Kentaro Kimura, Lecsy Gonzalez, Krandhasi Kodaiarasu, Christian Miller, Ikue Umemoto, Keitaro Murayama, Tomohiro Nakao, et al. Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol. BMJ open. 2023. 13. 3. e069386
The clinical characterization of the adult patient with depression aimed at personalization of management
https://www.jspn.or.jp/modules/activity/index.php?content_id=313 2020
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics
https://www.jspn.or.jp/modules/activity/index.php?content_id=285 2020
The revised German evidence- and consensus-based schizophrenia guideline
https://www.jspn.or.jp/modules/activity/index.php?content_id=285 2020
20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
https://www.jspn.or.jp/modules/activity/index.php?content_id=285 2020
Impacts of post-COVID-19 conditions and neuropsychiatric symptoms in a sample of Japanese individuals: A mixed-methods study
(27th World Congress of the International College of Psychosomatic Medicine 2024)
CLINICAL LIAISON PSYCHIATRY IN JAPAN: Current Status, Challenges, and Future Perspectives
(27th World Congress of the International College of Psychosomatic Medicine 2024)